PulseTrendingJournal ClubResearchersJournalsExplore
Instagram
HomeTrendingJournal ClubExplore
Synapse
⌘+K
Synapse
June 13, 2012Clinical Cancer Research

A Multicenter Phase I Trial of PX-866, an Oral Irreversible Phosphatidylinositol 3-Kinase Inhibitor, in Patients with Advanced Solid Tumors

View Full Paper
Ask AI
Bookmark
Share

Authors

DHDavid S. HongDBDaniel W. BowlesGFGerald S. Falchook

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hong et al. (2012) studied this question.

synapsesocial.com/papers/6a0efb6606ecbe8334480759https://doi.org/10.1158/1078-0432.ccr-12-0714
View Full Paper
Ask AI
Bookmark
Share